Publication | Closed Access
Nanocurcumin as an Add-on to Antipsychotic Drugs for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia
20
Citations
29
References
2020
Year
The present study indicates nanocurcumin as a safe and potential adjunctive treatment strategy for treatment of primary negative symptoms of schizophrenia.
| Year | Citations | |
|---|---|---|
Page 1
Page 1